We are proud to announce that HTL Biotechnology has recently received Halal certification for two of our key products: DNA and HANa. Discover our press release.
Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.
CPHI China is one of Asia’s leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,
At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.
On the occasion of the first National Bioproduction and Biomedicine Day, which took place on the last 5th july, we were very proud to welcome a TVR journalist in our Javené site for an exclusive report.
We are delighted to announce that HTL Biotechnology has once again been awarded the EcoVadis Gold 2024 label for its Corporate Social Responsibility (CSR) performance!
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage.
HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow (Nutley, NJ). Notably, this acquisition includes Modern Meadow’s platform of recombinant proteins, with the most advanced product being human recombinant collagen type III (rhCOL3).
As every year, the In-Cosmetics Global Congress returns to Paris, with top industry leaders and experts gathering under one roof.
This event promises opportunities and insights into the future of Cosmetics.
France BioLead structures, pilots, supports and promotes the French biomanufacturing sector.
AMWC, the Aesthetic & Anti-Aging Medicine World Congress in Monaco.
PCHi is an annual gathering of professionals from the cosmetics and aesthetics industry, featuring formulators, manufacturers and R&D experts from all over the world.
